22 Jul 2022
New research, published in Diabetes, indicates that sRAGE may prevent type 1 diabetes by correcting faulty regulatory T-cells to counter the autoimmune response and may also be useful in treating existing type 1 diabetes.
News Medical
NEW Research SIG
07 Jan 2025
ISE selects Bioscientifica as its association management provider
01 Jan 2025
Division Chief of Endocrinology
01 Jan 2025
Society members recognised in New Year Honours List
01 Jan 2025